Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

First recipient of pig kidney transplant dies two months after surgery

Reading Time: < 1 minute

Richard Slayman, the first person to undergo a genetically modified pig kidney transplant, has tragically passed away at the age of 62. Richard had received the groundbreaking transplantation in March of this year, in a bid to combat his end-stage kidney disease.

In a statement released by the Mass General transplant team, they expressed their deep sadness at Richard’s sudden passing. They emphasized that there was no indication that his death was a result of the recent transplant. The hospital hailed Richard as a beacon of hope for transplant patients worldwide and commended his willingness to advance the field of xenotransplantation.

Richard’s journey with kidney disease had been a challenging one. After a failed human kidney transplant in 2018, he turned to the innovative option of a pig kidney transplant. Following the surgery on March 16, Richard no longer required dialysis, and his new organ was functioning well.

Xenotransplantation, the process of transplanting organs from one species to another, holds promise for addressing organ shortages and treating life-threatening conditions like organ failure. Despite challenges such as immune rejection and disease transmission risks, advancements in genetic engineering and organ preservation techniques aim to overcome these obstacles.

Richard’s family shared that his decision to undergo the procedure was driven by a desire to provide hope for the thousands of people in need of transplants. They emphasized that his legacy of hope and optimism will endure, inspiring patients, researchers, and healthcare professionals alike.

The passing of Richard Slayman serves as a poignant reminder of the complexities and possibilities within the realm of medical science and transplantation. His courage and contribution to the field will not be forgotten.

Taylor Swifts New Album Release Health issues from using ACs Boston Marathon 2024 15 Practical Ways To Save Money